A return of Chinese travellers, who spent almost US$248 billion on trips abroad in 2019 before the pandemic, is key to filling a big hole in the global travel industry.
HONG KONG, July 28, 2023 /PRNewswire/ In the face of ever-changing circumstances, technological innovation remains the eternal driving force behind the long-term growth of biopharmaceutical.
WATERTOWN, Mass., July 20, 2023 /PRNewswire/ Riparian Pharmaceuticals, a Viva Biotech portfolio company, is a biotechnology company focused on discovering novel therapeutics for cardiovascular.
/PRNewswire/ DTx Pharma, invested and incubated by Viva BioInnovator (VBI), is a preclinical stage biotechnology company addressing the delivery challenges.